Biostar Pharma (BSPM) Tops Q4 Views
Tweet Send to a FriendGet Alerts BSPM Hot Sheet
Trade BSPM Now!
Biostar Pharmaceuticals (Nasdaq: BSPM) reported Q4 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $28.2 million versus the consensus estimate of $27.58 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- Deswell Industries, Inc. (DSWL) Posts Q4 Loss of 12c/Share
- American Superconductor (AMSC) Reports In-Line Q4 EPS; Guides Q1
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
